COCRYSTAL PHARMA, INC. Operating Cash Flow
COCRYSTAL PHARMA, INC. (COCP) reported Operating Cash Flow of -$4.86 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-13
- COCRYSTAL PHARMA, INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$2.52M.
- COCRYSTAL PHARMA, INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$2.34M.
- COCRYSTAL PHARMA, INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$1.74M.
- COCRYSTAL PHARMA, INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$1.36M.
- COCRYSTAL PHARMA, INC. net cash provided by (used in) operating activities for fiscal 2025 was -$8.19M.
- COCRYSTAL PHARMA, INC. net cash provided by (used in) operating activities for fiscal 2024 was -$16.48M.
- COCRYSTAL PHARMA, INC. net cash provided by (used in) operating activities for fiscal 2023 was -$14.67M.
- COCRYSTAL PHARMA, INC. net cash provided by (used in) operating activities for fiscal 2022 was -$21.43M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed | Net Cash Provided by (Used in) Operating Activities 87 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$2.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$4.86M 10-Q · filed 2026-08-13 | -$6.59M derived: sum of 3 quarters · filed 2026-08-13 | -$7.95M derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2026-03-31 | -$2.34M 10-Q · filed 2026-05-15 | -$4.08M derived: sum of 2 quarters · filed 2026-05-15 | -$5.44M derived: sum of 3 quarters · filed 2026-05-15 | -$7.59M derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2025-12-31 | -$1.74M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$3.10M derived: sum of 2 quarters · filed 2026-03-31 | -$5.25M derived: sum of 3 quarters · filed 2026-08-13 | -$8.19M 10-K · filed 2026-03-31 | ||
| 2025-09-30 | -$1.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$3.52M derived: sum of 2 quarters · filed 2026-08-13 | -$6.46M 10-Q · filed 2025-11-14 | -$9.62M derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2025-06-30 | -$2.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$5.09M 10-Q · filed 2026-08-13 | -$8.25M derived: sum of 3 quarters · filed 2026-08-13 | -$13.38M derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2025-03-31 | -$2.94M 10-Q · filed 2026-05-15 | -$6.10M derived: sum of 2 quarters · filed 2026-05-15 | -$11.22M derived: sum of 3 quarters · filed 2026-05-15 | -$14.92M derived: sum of 4 quarters · filed 2026-05-15 | ||
| 2024-12-31 | -$3.16M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$8.28M derived: sum of 2 quarters · filed 2026-03-31 | -$11.98M derived: sum of 3 quarters · filed 2026-03-31 | -$16.48M 10-K · filed 2026-03-31 | ||
| 2024-09-30 | -$5.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$8.82M derived: sum of 2 quarters · filed 2025-11-14 | -$13.32M 10-Q · filed 2025-11-14 | -$16.65M derived: sum of 4 quarters · filed 2025-11-14 | ||
| 2024-06-30 | -$3.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$8.20M 10-Q · filed 2025-08-14 | -$11.53M derived: sum of 3 quarters · filed 2025-08-14 | -$14.21M derived: sum of 4 quarters · filed 2025-08-14 | ||
| 2024-03-31 | -$4.50M 10-Q · filed 2025-05-15 | -$7.83M derived: sum of 2 quarters · filed 2025-05-15 | -$10.51M derived: sum of 3 quarters · filed 2025-05-15 | -$16.06M derived: sum of 4 quarters · filed 2025-05-15 | ||
| 2023-12-31 | -$3.33M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$6.01M derived: sum of 2 quarters · filed 2025-03-31 | -$11.55M derived: sum of 3 quarters · filed 2025-03-31 | -$14.67M 10-K · filed 2025-03-31 | ||
| 2023-09-30 | -$2.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | -$8.23M derived: sum of 2 quarters · filed 2024-11-13 | -$11.34M 10-Q · filed 2024-11-13 | -$16.23M derived: sum of 4 quarters · filed 2024-11-13 | ||
| 2023-06-30 | -$5.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$8.66M 10-Q · filed 2024-08-14 | -$13.55M derived: sum of 3 quarters · filed 2024-08-14 | -$22.46M derived: sum of 4 quarters · filed 2024-08-14 | ||
| 2023-03-31 | -$3.11M 10-Q · filed 2024-05-13 | -$8.00M derived: sum of 2 quarters · filed 2024-05-13 | -$16.91M derived: sum of 3 quarters · filed 2024-05-13 | -$20.64M derived: sum of 4 quarters · filed 2024-05-13 | ||
| 2022-12-31 | -$4.89M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | -$13.80M derived: sum of 2 quarters · filed 2024-03-28 | -$17.52M derived: sum of 3 quarters · filed 2024-03-28 | -$21.43M 10-K · filed 2024-03-28 | ||
| 2022-09-30 | -$8.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$12.63M derived: sum of 2 quarters · filed 2023-11-13 | -$16.54M 10-Q · filed 2023-11-13 | -$19.46M derived: sum of 4 quarters · filed 2023-11-13 | ||
| 2022-06-30 | -$3.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$7.63M 10-Q · filed 2023-08-14 | -$10.56M derived: sum of 3 quarters · filed 2023-08-14 | -$15.96M derived: sum of 4 quarters · filed 2023-08-14 | ||
| 2022-03-31 | -$3.91M 10-Q · filed 2023-05-15 | -$6.83M derived: sum of 2 quarters · filed 2023-05-15 | -$12.23M derived: sum of 3 quarters · filed 2023-05-15 | -$14.86M derived: sum of 4 quarters · filed 2023-05-15 | ||
| 2021-12-31 | -$2.92M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | -$8.32M derived: sum of 2 quarters · filed 2023-03-29 | -$10.95M derived: sum of 3 quarters · filed 2023-03-29 | -$12.72M 10-K · filed 2023-03-29 | ||
| 2021-09-30 | -$5.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$8.03M derived: sum of 2 quarters · filed 2022-11-14 | -$9.80M 10-Q · filed 2022-11-14 | -$12.18M derived: sum of 4 quarters · filed 2022-11-14 | ||
| 2021-06-30 | -$2.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | -$4.39M 10-Q · filed 2022-08-15 | -$6.78M derived: sum of 3 quarters · filed 2022-08-15 | -$9.84M derived: sum of 4 quarters · filed 2022-08-15 | ||
| 2021-03-31 | -$1.77M 10-Q · filed 2022-05-11 | -$4.15M derived: sum of 2 quarters · filed 2022-05-11 | -$7.21M derived: sum of 3 quarters · filed 2022-05-11 | -$9.41M derived: sum of 4 quarters · filed 2022-05-11 | ||
| 2020-12-31 | -$2.38M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23 | -$5.44M derived: sum of 2 quarters · filed 2022-03-23 | -$7.64M derived: sum of 3 quarters · filed 2022-03-23 | -$9.83M 10-K · filed 2022-03-23 | ||
| 2020-09-30 | -$3.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | -$5.26M derived: sum of 2 quarters · filed 2021-11-15 | -$7.45M 10-Q · filed 2021-11-15 | -$8.68M derived: sum of 4 quarters · filed 2021-11-15 | ||
| 2020-06-30 | -$2.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | -$4.39M 10-Q · filed 2021-08-16 | -$5.62M derived: sum of 3 quarters · filed 2021-08-16 | -$6.94M derived: sum of 4 quarters · filed 2021-08-16 | ||
| 2020-03-31 | -$2.19M 10-Q · filed 2021-05-17 | -$3.42M derived: sum of 2 quarters · filed 2021-05-17 | -$4.74M derived: sum of 3 quarters · filed 2021-05-17 | -$5.77M derived: sum of 4 quarters · filed 2021-05-17 | ||
| 2019-12-31 | -$1.23M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-17 | -$2.55M derived: sum of 2 quarters · filed 2021-03-17 | -$3.58M derived: sum of 3 quarters · filed 2021-03-17 | -$1.56M 10-K · filed 2021-03-17 | ||
| 2019-09-30 | -$1.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | -$2.35M derived: sum of 2 quarters · filed 2020-11-13 | -$333.00K 10-Q · filed 2020-11-13 | -$2.30M derived: sum of 4 quarters · filed 2020-11-13 | ||
| 2019-06-30 | -$1.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $990.00K 10-Q · filed 2020-08-06 | -$980.00K derived: sum of 3 quarters · filed 2020-08-06 | -$3.13M derived: sum of 4 quarters · filed 2020-08-06 | ||
| 2019-03-31 | $2.02M 10-Q · filed 2020-05-13 | $48.00K derived: sum of 2 quarters · filed 2020-05-13 | -$2.10M derived: sum of 3 quarters · filed 2020-05-13 | -$4.19M derived: sum of 4 quarters · filed 2020-05-13 | ||
| 2018-12-31 | -$1.97M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | -$4.12M derived: sum of 2 quarters · filed 2020-03-27 | -$6.21M derived: sum of 3 quarters · filed 2020-03-27 | -$8.29M 10-K · filed 2020-03-27 | ||
| 2018-09-30 | -$2.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$4.24M derived: sum of 2 quarters · filed 2019-11-12 | -$6.32M 10-Q · filed 2019-11-12 | -$7.90M derived: sum of 4 quarters · filed 2019-11-12 | ||
| 2018-06-30 | -$2.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | -$4.17M 10-Q · filed 2019-08-09 | -$5.75M derived: sum of 3 quarters · filed 2019-08-09 | -$7.94M derived: sum of 4 quarters · filed 2019-08-09 | ||
| 2018-03-31 | -$2.08M 10-Q · filed 2019-05-10 | -$3.66M derived: sum of 2 quarters · filed 2019-05-10 | -$5.84M derived: sum of 3 quarters · filed 2019-05-10 | -$6.93M derived: sum of 4 quarters · filed 2019-05-10 | ||
| 2017-12-31 | -$1.58M derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | -$3.77M derived: sum of 2 quarters · filed 2019-04-01 | -$4.85M derived: sum of 3 quarters · filed 2019-04-01 | -$6.90M 10-K · filed 2019-04-01 | ||
| 2017-09-30 | -$2.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | -$3.27M derived: sum of 2 quarters · filed 2018-11-09 | -$5.32M 10-Q · filed 2018-11-09 | -$7.62M derived: sum of 4 quarters · filed 2018-11-09 | ||
| 2017-06-30 | -$1.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | -$3.14M 10-Q · filed 2018-08-09 | -$5.44M derived: sum of 3 quarters · filed 2018-08-09 | -$8.58M derived: sum of 4 quarters · filed 2018-08-09 | ||
| 2017-03-31 | -$2.05M 10-Q · filed 2018-05-10 | -$4.35M derived: sum of 2 quarters · filed 2018-05-10 | -$7.50M derived: sum of 3 quarters · filed 2018-05-10 | -$12.60M derived: sum of 4 quarters · filed 2018-05-10 | ||
| 2016-12-31 | -$2.30M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-21 | -$5.45M derived: sum of 2 quarters · filed 2018-03-21 | -$10.55M derived: sum of 3 quarters · filed 2018-03-21 | -$14.65M 10-K · filed 2018-03-21 | ||
| 2016-09-30 | -$3.15M 10-Q · filed 2016-11-09 | -$8.25M derived: sum of 2 quarters · filed 2016-11-09 | -$12.35M 10-Q · filed 2017-11-08 | -$15.33M derived: sum of 4 quarters · filed 2018-03-21 | ||
| 2016-06-30 | -$5.10M 10-Q · filed 2016-08-09 | -$9.21M 10-Q · filed 2017-08-08 | -$12.18M derived: sum of 3 quarters · filed 2018-03-21 | -$15.37M derived: sum of 4 quarters · filed 2018-03-21 | ||
| 2016-03-31 | -$4.04M 10-Q · filed 2017-05-10 | -$7.08M derived: sum of 2 quarters · filed 2018-03-21 | -$10.27M derived: sum of 3 quarters · filed 2018-03-21 | -$12.80M derived: sum of 4 quarters · filed 2018-03-21 | ||
| 2015-12-31 | -$3.04M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-21 | -$6.23M derived: sum of 2 quarters · filed 2018-03-21 | -$8.76M derived: sum of 3 quarters · filed 2018-03-21 | -$10.32M 10-K · filed 2018-03-21 | ||
| 2015-09-30 | -$3.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | -$5.72M derived: sum of 2 quarters · filed 2016-11-09 | -$7.28M 10-Q · filed 2016-11-09 | -$9.03M derived: sum of 4 quarters · filed 2017-03-31 | ||
| 2015-06-30 | -$2.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | -$4.09M 10-Q · filed 2016-08-09 | -$5.84M derived: sum of 3 quarters · filed 2017-03-31 | -$6.98M derived: sum of 4 quarters · filed 2017-03-31 | ||
| 2015-03-31 | -$1.56M 10-Q · filed 2016-05-10 | -$3.31M derived: sum of 2 quarters · filed 2017-03-31 | -$4.45M derived: sum of 3 quarters · filed 2017-03-31 | -$5.79M derived: sum of 4 quarters · filed 2017-03-31 | ||
| 2014-12-31 | -$1.75M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | -$2.89M derived: sum of 2 quarters · filed 2017-03-31 | -$4.23M derived: sum of 3 quarters · filed 2017-03-31 | -$6.01M 10-K · filed 2017-03-31 | -$6.01M 10-K · filed 2015-03-31 | |
| 2014-09-30 | -$1.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-16 | -$2.48M derived: sum of 2 quarters · filed 2015-11-16 | -$4.26M 10-Q · filed 2015-11-16 | -$5.07M derived: sum of 4 quarters · filed 2015-11-16 | ||
| 2014-06-30 | -$1.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-14 | -$3.12M 10-Q · filed 2015-08-14 | -$3.93M derived: sum of 3 quarters · filed 2015-08-14 | -$4.87M derived: sum of 4 quarters · filed 2015-08-14 | ||
| 2014-03-31 | -$1.78M 10-Q · filed 2015-05-14 | -$2.59M derived: sum of 2 quarters · filed 2015-05-14 | -$3.54M derived: sum of 3 quarters · filed 2015-05-14 | -$4.51M derived: sum of 4 quarters · filed 2015-05-14 | -$16.98M 10-Q · filed 2014-05-15 | |
| 2013-12-31 | -$808.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-31 | -$1.76M derived: sum of 2 quarters · filed 2015-03-31 | -$2.73M derived: sum of 3 quarters · filed 2015-03-31 | -$3.69M 10-K · filed 2015-03-31 | -$4.57M 10-K · filed 2014-03-31 | |
| 2013-09-30 | -$948.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | -$1.93M derived: sum of 2 quarters · filed 2014-11-14 | -$2.88M 10-Q · filed 2014-11-14 | |||
| 2013-06-30 | -$978.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | -$1.93M 10-Q · filed 2014-08-14 | ||||
| 2013-03-31 | -$952.00K 10-Q · filed 2014-05-15 | |||||
| 2012-12-31 | -$1.59M 10-K · filed 2014-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |